Diethylstilbestrol in pregnancy: an update

Area of Science:

• Endocrinology
• Reproductive Health
• Teratology

Background:

• Diethylstilbestrol (DES) is a synthetic estrogen formerly prescribed to prevent pregnancy complications.
• Decades of use revealed significant adverse health effects in both mothers and offspring.
• The long-term consequences of prenatal DES exposure are a critical public health concern.

Purpose of the Study:

• To review the historical use and subsequent understanding of diethylstilbestrol (DES).
• To highlight the adverse outcomes associated with DES exposure in pregnancy.
• To emphasize the importance of recognizing DES-related health issues in affected individuals.

Main Methods:

• Review of historical medical literature and epidemiological data.
• Analysis of patient outcomes following maternal DES administration.
• Synthesis of evidence linking DES to specific health conditions.

Main Results:

• Initial perceived benefits of DES in pregnancy were not substantiated by subsequent research.
• A range of health problems have been documented in DES-exposed mothers and their offspring.
• These issues include reproductive tract abnormalities, cancers, and other long-term effects.

Conclusions:

• The use of diethylstilbestrol (DES) in pregnancy was ultimately found to be harmful.
• Knowledge of DES-associated pathologies is essential for the clinical management of exposed patients.
• Continued vigilance and research are necessary to address the health legacy of DES.